content: <?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
    <!-- Generated by Workiva -->
    <headerData>
      <submissionType>144</submissionType>
      <filerInfo>
        <filer>
          <filerCredentials>
            <cik>0001273885</cik>
            <ccc>XXXXXXXX</ccc>
          </filerCredentials>
        </filer>
        <liveTestFlag>LIVE</liveTestFlag>
  
  
  
      </filerInfo>
    </headerData>
    <formData>
      <issuerInfo>
        <issuerCik>0001593899</issuerCik>
        <issuerName>Atea Pharmaceuticals, Inc</issuerName>
        <secFileNumber>001-39661</secFileNumber>
        <issuerAddress>
          <com:street1>225 Franklin St, Suite 2100</com:street1>
          <com:city>Boston</com:city>
          <com:stateOrCountry>MA</com:stateOrCountry>
          <com:zipCode>02110</com:zipCode>
        </issuerAddress>
        <issuerContactPhone>857-204-8109</issuerContactPhone>
        <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Franklin Berger</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
        <relationshipsToIssuer>
          <relationshipToIssuer>Lead Independent Director</relationshipToIssuer>
        </relationshipsToIssuer>
      </issuerInfo>
      <securitiesInformation>
        <securitiesClassTitle>Common</securitiesClassTitle>
        <brokerOrMarketmakerDetails>
          <name>J.P. Morgan Securities LLC</name>
          <address>
            <com:street1>390 Madison Avenue</com:street1>
            <com:street2>6th Floor</com:street2>
            <com:city>New York</com:city>
            <com:stateOrCountry>NY</com:stateOrCountry>
            <com:zipCode>10017</com:zipCode>
          </address>
        </brokerOrMarketmakerDetails>
        <noOfUnitsSold>359606</noOfUnitsSold>
        <aggregateMarketValue>1023475</aggregateMarketValue>
        <noOfUnitsOutstanding>84463059</noOfUnitsOutstanding>
        <approxSaleDate>12/10/2024</approxSaleDate>
        <securitiesExchangeName>Nasdaq</securitiesExchangeName>
      </securitiesInformation>
      <securitiesToBeSold>
        <securitiesClassTitle>Common</securitiesClassTitle>
        <acquiredDate>08/10/2016</acquiredDate>
        <natureOfAcquisitionTransaction>Investment</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>132014</amountOfSecuritiesAcquired>
        <paymentDate>08/10/2016</paymentDate>
        <natureOfPayment>Funds Transfer</natureOfPayment>
      </securitiesToBeSold>
      <securitiesToBeSold>
        <securitiesClassTitle>Common</securitiesClassTitle>
        <acquiredDate>06/29/2018</acquiredDate>
        <natureOfAcquisitionTransaction>Investment</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>131578</amountOfSecuritiesAcquired>
        <paymentDate>06/29/2018</paymentDate>
        <natureOfPayment>Funds Transfer</natureOfPayment>
      </securitiesToBeSold>
      <securitiesToBeSold>
        <securitiesClassTitle>Common</securitiesClassTitle>
        <acquiredDate>05/19/2020</acquiredDate>
        <natureOfAcquisitionTransaction>Investment</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>60540</amountOfSecuritiesAcquired>
        <paymentDate>05/19/2020</paymentDate>
        <natureOfPayment>Funds Transfer</natureOfPayment>
      </securitiesToBeSold>
      <securitiesToBeSold>
        <securitiesClassTitle>Common</securitiesClassTitle>
        <acquiredDate>10/12/2020</acquiredDate>
        <natureOfAcquisitionTransaction>Investment</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>35474</amountOfSecuritiesAcquired>
        <paymentDate>10/12/2020</paymentDate>
        <natureOfPayment>Funds Transfer</natureOfPayment>
      </securitiesToBeSold>
      <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
      <noticeSignature>
        <noticeDate>12/10/2024</noticeDate>
        <signature>/s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for Franklin Berger</signature>
      </noticeSignature>
    </formData>
  </edgarSubmission>
metadata_documents: [{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 4459}]
text: 144
  0001273885
  XXXXXXXX
  LIVE
  0001593899
  Atea Pharmaceuticals, Inc
  001-39661
  225 Franklin St, Suite 2100
  Boston
  MA
  02110
  857-204-8109
  Franklin Berger
  Lead Independent Director
  Common
  J.P. Morgan Securities LLC
  390 Madison Avenue
  6th Floor
  New York
  NY
  10017
  359606
  1023475
  84463059
  12/10/2024
  Nasdaq
  Common
  08/10/2016
  Investment
  Issuer
  N
  132014
  08/10/2016
  Funds Transfer
  Common
  06/29/2018
  Investment
  Issuer
  N
  131578
  06/29/2018
  Funds Transfer
  Common
  05/19/2020
  Investment
  Issuer
  N
  60540
  05/19/2020
  Funds Transfer
  Common
  10/12/2020
  Investment
  Issuer
  N
  35474
  10/12/2020
  Funds Transfer
  Y
  12/10/2024
  /s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for Franklin Berger